Holding(s) in Company
Coms PLC
For filings with the FSA include the annex |
For filings with issuer exclude the annex |
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Â | Coms Plc |
2 Reason for the notification (please tick the appropriate box or boxes): |
An acquisition or disposal of voting rights | Â | X | |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | Â | ||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | Â | ||
An event changing the breakdown of voting rights | Â | ||
Other (please specify): | Â | Â |
3. Full name of person(s) subject to the notification obligation: iii | Â |
Cantor Fitzgerald Europe |
4. Full name of shareholder(s) (if different from 3.):iv |
N/A |
|
5. Date of the transaction and date on which the threshold is crossed or reached: v |
02/12/09 |
|
6. Date on which issuer notified: |
03/12/09 |
|
7. Threshold(s) that is/are crossed or reached: vi, vii |
Below 5% |
|
8. Notified details: | TR1 sent to FSA, Coms plc |
A: Voting rights attached to shares viii, ix
Class/type of shares
|
 |
Situation previous to the triggering transaction |
 |
Resulting situation after the triggering transaction |
|||||||||||||||||||
Number of Shares |
 |
Number of Voting Rights |
Number of shares |
 |
Number of voting rights |
 |
% of voting rights x |
||||||||||||||||
 |  |  | Direct | Direct xi |  | Indirect xii | Direct |  | Indirect | ||||||||||||||
Ordinary
GB00B3CDXQ41 |
3,877,000 | 3,877,000 | 1,826,000 | 1,826,000 | Â | 4.33% | Â | ||||||||||||||||
 | |||||||||||||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||
Type of financial instrument |
 |
Expiration date xiii |
 |
Exercise/ Conversion Period xiv |
 |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
 |
% of voting rights |
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||
Resulting situation after the triggering transaction | |||||||||||||
Type of financial instrument |
 |
Exercise price |
 |
Expiration date xvii |
 |
Exercise/ Conversion period xviii |
 |
Number of voting rights instrument refers to |
 |
% of voting rights xix, xx |
|||
 |  |  |  |  | Nominal |  | Delta |
Total (A+B+C) | ||
Number of voting rights | Â | Percentage of voting rights |
1,826,000 | 4.33% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
Proxy Voting: | ||
10. Name of the proxy holder: | Â | N/A |
11. Number of voting rights proxy holder will cease to hold: | N/A | |
12. Date on which proxy holder will cease to hold voting rights: | N/A |
13. Additional information: | Â | Â |
14. Contact name: | Simon Chatterton | |
15. Contact telephone number: | 020 7894 7990 |
Note: Annex should only be submitted to the FSA not the issuer |
Annex: Notification of major interests in sharesxxii |
A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)(including legal form of legal entities) |
 | Cantor Fitzgerald Europe |
Contact address (registered office for legal entities)(registered office for legal entities) |
17 Crosswall, London EC3N 2LB | |
Phone number & email | 020 7894 8848 | |
Other useful information (at least legal representative for legal persons) (at least legal representative for legal persons) |
Kevin Taylor |
B: Identity of the notifier, if applicable
Full name | Â | Â |
Contact address | Â | |
Phone number & email | Â | |
Other useful information(e.g. functional relationship with the person or legal entity subject to the notification obligation) | Â |
C: Additional information |
For notes on how to complete form TR-1 please see the FSA website.